Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker CPHI
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Jul 22, 2026 | CPHI China Pharma Holdings, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 22, 2026 | CPHI China Pharma Holdings, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 3, 2026 | CPHI China Pharma Holdings, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Mar 3, 2026 | CPHI China Pharma Holdings, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 10, 2026 | CPHI China Pharma Holdings, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Feb 10, 2026 | CPHI China Pharma Holdings, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 6, 2026 | CPHI China Pharma Holdings, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Dec 23, 2025 | CPHI China Pharma Holdings, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Dec 23, 2025 | CPHI China Pharma Holdings, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 10, 2025 | CPHI China Pharma Holdings, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Dec 10, 2025 | CPHI China Pharma Holdings, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 4, 2025 | CPHI China Pharma Holdings, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 26, 2024 | CPHI China Pharma Holdings, Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 26, 2024 | CPHI China Pharma Holdings, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Dec 13, 2024 | CPHI China Pharma Holdings, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
15 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:14 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances